EUVIMEDEUVIMED entdecken
Crossref

Delineating the Mechanism of Action of the Repurposed Drug Benzatropine against Mycobacterium tuberculosis

Dev Kiran Nayak, Abtar Mishra, Ritu Sharaya, Mousumi Das, Saurabh Chugh, Prabhakar Babele, Amit Kumar Yadav, Ramandeep Singh, Rohan Dhiman, Niranjana Sri Sundaramoorthy

ACS Infectious Diseases · 13.11.2026

DOI: 10.1021/acsinfecdis.6c00051 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 13.11.2026. Verfasst von Dev Kiran Nayak und 9 weiteren Autor:innen. Die Arbeit nennt 75 Literaturangaben. Gefördert von: Department of Biotechnology, Ministry of Science and Technology, India, Department of Science and Technology, Ministry of Science and Technology, India, Department of Science and Technology, Government of Odisha.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, we have performed luminescence-based screening assays and identified benzatropine, an FDA-approved drug that inhibits the intracellular growth of drug-sensitive and drug-resistant M. tuberculosis strains. We demonstrate that oral administration of benzatropine inhibits the growth of M. tuberculosis in aerosol-infected mice. Furthermore, we show that benzatropine enhances the activity of rifampicin and pretomanid against M. tuberculosis in THP-1 macrophages. Detailed analysis of the proteomics data revealed that, in comparison to the untreated and infected macrophages, the relative expression of several autophagy-related proteins was altered in benzatropine-treated and M. tuberculosis-infected macrophages. We demonstrate that exposure to benzatropine reduced phosphorylation of JAK2 and STAT3, increased intracellular ROS and calcium levels, and induced autophagy in macrophages. We further report that preincubation with histamine, wortmannin, and N-acetylcysteine reduced benzatropine’s ability to induce autophagy and inhibit the growth of intracellular bacteria. Also, activation of STAT3 signaling with colivelin and inhibition of AMPK signalling with compound C reduced benzatropine-induced autophagy. Taken together, we have shown that benzatropine, an FDA-approved drug, induces autophagy and inhibits the growth of intracellular drug-sensitive and drug-resistant M. tuberculosis.

Förderung

  • Department of Biotechnology, Ministry of Science and Technology, India
  • Department of Science and Technology, Ministry of Science and Technology, India
  • Department of Science and Technology, Government of Odisha

Zitieren

APA

Nayak, D. K., Mishra, A., Sharaya, R., Das, M., Chugh, S., Babele, P., Yadav, A. K., Singh, R., Dhiman, R., & Sundaramoorthy, N. S. (2026). Delineating the Mechanism of Action of the Repurposed Drug Benzatropine against Mycobacterium tuberculosis. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.6c00051

Vancouver

Nayak DK, Mishra A, Sharaya R, Das M, Chugh S, Babele P, et al. Delineating the Mechanism of Action of the Repurposed Drug Benzatropine against Mycobacterium tuberculosis. ACS Infectious Diseases. 2026. doi:10.1021/acsinfecdis.6c00051

BibTeX
@article{Nayak2026,
  author = {Nayak, Dev Kiran and Mishra, Abtar and Sharaya, Ritu and Das, Mousumi and Chugh, Saurabh and Babele, Prabhakar and Yadav, Amit Kumar and Singh, Ramandeep and Dhiman, Rohan and Sundaramoorthy, Niranjana Sri},
  title = {Delineating the Mechanism of Action of the Repurposed Drug Benzatropine against Mycobacterium tuberculosis},
  journal = {ACS Infectious Diseases},
  year = {2026},
  doi = {10.1021/acsinfecdis.6c00051}
}
Kostenlos starten →